Form D · Other Health Care
CLOZEX MEDICAL, INC.
W. Bridgewater, MA · CIK 0001757168
Offering snapshot reported Mar 8, 2024 · SEC filing
- Reported sold
- $3M Offering amount: $3M
- Investors reported
- 27 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Nov 1, 2023 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Mar 8, 2024 | Initial | $2,999,529 | No comparison | 27 | SEC filing |
| Feb 12, 2021 | Initial | $2,951,647 | No comparison | 35 | SEC filing |
| Jun 12, 2019 | Amendment | $4,483,015 | $714,770vs Oct 30, 2018 | 46 | SEC filing |
| Oct 30, 2018 | Initial | $3,768,245 | No comparison | 39 | SEC filing |
Offering details
- Securities
- Debt
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-507041
Source: Form D, filed Mar 8, 2024. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Tony Antonaccio | Director |
| Joseph Cucolo | Director |
| Francis Fedorowicz | Executive |
| Joseph Lamb | Director |
| Dr. John Lazor | Director |
| Michael Lebner | Director |
| Mark Madden | Director, Executive |
| Nick Patterson | Director |
| Harry Rubash | Director |
| Dr. Harry Rubash | Director |
| John Schandler | Director |
| Gary Zentner | Director |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
375 West Street
W. Bridgewater, MA, 02379
W. Bridgewater, MA, 02379